2206 related articles for article (PubMed ID: 20110019)
1. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
2. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
Kuna P
Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
[TBL] [Abstract][Full Text] [Related]
3. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
4. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
6. Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.
Hirst C; Calingaert B; Stanford R; Castellsague J
J Asthma; 2010 May; 47(4):439-46. PubMed ID: 20528600
[TBL] [Abstract][Full Text] [Related]
7. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
8. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
9. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Nannini LJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
[TBL] [Abstract][Full Text] [Related]
10. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
11. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
Lyseng-Williamson KA; Plosker GL
Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
[TBL] [Abstract][Full Text] [Related]
12. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
Aballéa S; Cure S; Vogelmeier C; Wirén A
Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
[TBL] [Abstract][Full Text] [Related]
13. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Reynolds NA; Lyseng-Williamson KA; Wiseman LR
Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
[TBL] [Abstract][Full Text] [Related]
14. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
[TBL] [Abstract][Full Text] [Related]
15. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.
Mehta N; Aggarwal B; Gogtay J; Abdool-Gaffar S
Expert Opin Drug Deliv; 2015 Jun; 12(6):963-75. PubMed ID: 25429610
[TBL] [Abstract][Full Text] [Related]
16. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.
Nannini LJ; Poole P; Milan SJ; Kesterton A
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006826. PubMed ID: 23990350
[TBL] [Abstract][Full Text] [Related]
17. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD007694. PubMed ID: 20091646
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.
Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231
[TBL] [Abstract][Full Text] [Related]
19. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]